{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:43:50Z","timestamp":1791819830555,"version":"4.3.4"},"reference-count":79,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T00:00:00Z","timestamp":1526947200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hellenic Journal of Cardiology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.hjc.2018.05.008","type":"journal-article","created":{"date-parts":[[2018,5,25]],"date-time":"2018-05-25T14:07:53Z","timestamp":1527257273000},"page":"254-261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Current perspectives on the diagnosis and management of dilated cardiomyopathy Beyond heart failure: a Cardiomyopathy Clinic Doctor's point of view"],"prefix":"10.1016","volume":"59","author":[{"given":"Athanasios","family":"Bakalakos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Ritsatos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aris","family":"Anastasakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.hjc.2018.05.008_bib1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/eurheartj\/ehm342","article-title":"Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"29","author":"Elliott","year":"2008","journal-title":"Eur Heart J"},{"issue":"23","key":"10.1016\/j.hjc.2018.05.008_bib2","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/eurheartj\/ehv727","article-title":"Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases","volume":"37","author":"Pinto","year":"2016","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.hjc.2018.05.008_bib3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0033-0620(84)90020-3","article-title":"Classification and natural history of primary myocardial disease","volume":"27","author":"Abelmann","year":"1984","journal-title":"Prog Cardiovasc Dis"},{"issue":"4","key":"10.1016\/j.hjc.2018.05.008_bib4","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1001\/archinte.1950.00230160003001","article-title":"Clinically the myocardium","volume":"86","author":"Christian","year":"1950","journal-title":"AMA Arch Intern Med"},{"issue":"7008","key":"10.1016\/j.hjc.2018.05.008_bib5","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0140-6736(57)91537-4","article-title":"Uncommon myocardial diseases: the non-coronary cardiomyopathies","volume":"273","author":"Brigden","year":"1957","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.hjc.2018.05.008_bib6","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1136\/hrt.34.6.545","article-title":"The cardiomyopathies","volume":"34","author":"Goodwin","year":"1972","journal-title":"Br Heart J"},{"issue":"14","key":"10.1016\/j.hjc.2018.05.008_bib7","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1161\/CIRCULATIONAHA.106.174287","volume":"113","author":"Maron","year":"2006","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.hjc.2018.05.008_bib8","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/01.CIR.93.5.841","article-title":"Report of the 1995 World Health Organization\/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies","volume":"93","author":"Richardson","year":"1996","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.hjc.2018.05.008_bib9","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jacc.2014.05.027","article-title":"The MOGE(S) classification of cardiomyopathy for clinicians","volume":"64","author":"Arbustini","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"22","key":"10.1016\/j.hjc.2018.05.008_bib10","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/j.jacc.2013.10.008","article-title":"Classification of cardiomyopathies: evolution or revolution?","volume":"62","author":"Elliott","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.hjc.2018.05.008_bib11","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0735-1097(97)00434-8","article-title":"Frequency and phenotypes of familial dilated cardiomyopathy","volume":"31","author":"Gr\u00fcnig","year":"1998","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"23","key":"10.1016\/j.hjc.2018.05.008_bib12","doi-asserted-by":"crossref","first-page":"e579","DOI":"10.1161\/CIR.0000000000000455","article-title":"Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association","volume":"134","author":"Bozkurt","year":"2016","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.hjc.2018.05.008_bib13","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/europace\/euw362","article-title":"Sudden unexplained death in the young: epidemiology, aetiology and value of the clinically guided genetic screening","volume":"20","author":"Anastasakis","year":"2018","journal-title":"Europace"},{"issue":"11","key":"10.1016\/j.hjc.2018.05.008_bib14","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.jacc.2018.01.031","article-title":"The Diagnostic Yield of Brugada Syndrome After Sudden Death With Normal Autopsy","volume":"71","author":"Papadakis","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.hjc.2018.05.008_bib15","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.jacc.2004.11.066","article-title":"Clinical and genetic issues in familial dilated cardiomyopathy","volume":"45","author":"Burkett","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.hjc.2018.05.008_bib16","doi-asserted-by":"crossref","first-page":"108","DOI":"10.7326\/0003-4819-143-2-200507190-00009","article-title":"Echocardiographic evaluation in asymptomatic relatives of patients with dilated cardiomyopathy reveals preclinical disease","volume":"143","author":"Mahon","year":"2005","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.hjc.2018.05.008_bib17","first-page":"316","article-title":"Anderson-Fabry disease: a cardiomyopathy that can be cured","volume":"52","author":"Anastasakis","year":"2011","journal-title":"Hellenic J Cardiol"},{"issue":"33","key":"10.1016\/j.hjc.2018.05.008_bib18","doi-asserted-by":"crossref","first-page":"5997","DOI":"10.2174\/13816128113199990353","article-title":"Fabry disease and cardiovascular involvement","volume":"19","author":"Anastasakis","year":"2013","journal-title":"Curr Pharm Des"},{"issue":"3","key":"10.1016\/j.hjc.2018.05.008_bib19","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1161\/CIRCHEARTFAILURE.108.817346","article-title":"Progress with genetic cardiomyopathies: screening, counseling, and testing in dilated, hypertrophic, and arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"2","author":"Hershberger","year":"2009","journal-title":"Circ Heart Fail."},{"issue":"3","key":"10.1016\/j.hjc.2018.05.008_bib20","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/HCO.0b013e32835fb728","article-title":"Genetic testing in cardiovascular medicine: current landscape and future horizons","volume":"28","author":"Sturm","year":"2013","journal-title":"Curr Opin Cardiol"},{"issue":"2","key":"10.1016\/j.hjc.2018.05.008_bib21","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cardfail.2009.01.006","article-title":"Genetic evaluation of cardiomyopathy\u2013a Heart Failure Society of America practice guideline","volume":"15","author":"Hershberger","year":"2009","journal-title":"J\u00a0Card Fail"},{"issue":"8","key":"10.1016\/j.hjc.2018.05.008_bib22","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.hrthm.2011.05.020","article-title":"HRS\/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)","volume":"8","author":"Ackerman","year":"2011","journal-title":"Heart Rhythm"},{"issue":"5","key":"10.1016\/j.hjc.2018.05.008_bib23","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"17","key":"10.1016\/j.hjc.2018.05.008_bib24","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1016\/j.jacc.2017.02.046","article-title":"Utility of Post-Mortem Genetic Testing in Cases of Sudden Arrhythmic Death Syndrome","volume":"69","author":"Lahrouchi","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"16","key":"10.1016\/j.hjc.2018.05.008_bib25","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.jacc.2011.01.015","article-title":"Update 2011: clinical and genetic issues in familial dilated cardiomyopathy","volume":"57","author":"Hershberger","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.hjc.2018.05.008_bib26","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1161\/CIRCGENETICS.111.961805","article-title":"Evaluating pathogenicity of rare variants from dilated cardiomyopathy in the exome era","volume":"5","author":"Norton","year":"2012","journal-title":"Circ Cardiovasc Genet."},{"issue":"6","key":"10.1016\/j.hjc.2018.05.008_bib27","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1161\/CIRCGENETICS.112.963421","article-title":"Cardiac structural and sarcomere genes associated with cardiomyopathy exhibit marked intolerance of genetic variation","volume":"5","author":"Pan","year":"2012","journal-title":"Circ Cardiovasc Genet."},{"issue":"7","key":"10.1016\/j.hjc.2018.05.008_bib28","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1056\/NEJMoa1110186","article-title":"Truncations of titin causing dilated cardiomyopathy","volume":"366","author":"Herman","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.hjc.2018.05.008_bib29","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1161\/CIRCGENETICS.111.000062","article-title":"Exome sequencing and genome-wide linkage analysis in 17 families illustrate the complex contribution of TTN truncating variants to dilated cardiomyopathy","volume":"6","author":"Norton","year":"2013","journal-title":"Circ Cardiovasc Genet."},{"issue":"24","key":"10.1016\/j.hjc.2018.05.008_bib30","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1136\/heartjnl-2015-308190","article-title":"Genetic causes of dilated cardiomyopathy","volume":"102","author":"Favalli","year":"2016","journal-title":"Heart"},{"issue":"23","key":"10.1016\/j.hjc.2018.05.008_bib31","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1056\/NEJM200012073432304","article-title":"Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy","volume":"343","author":"Kamisago","year":"2000","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.hjc.2018.05.008_bib32","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ahj.2008.01.026","article-title":"Lamin A\/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy","volume":"156","author":"Parks","year":"2008","journal-title":"Am Heart J"},{"issue":"6","key":"10.1016\/j.hjc.2018.05.008_bib33","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.ahj.2007.07.038","article-title":"High yield of LMNA mutations in patients with dilated cardiomyopathy and\/or conduction disease referred to cardiogenetics outpatient clinics","volume":"154","author":"Van tintelen","year":"2007","journal-title":"Am Heart J"},{"issue":"3","key":"10.1016\/j.hjc.2018.05.008_bib34","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/HCO.0b013e32835f0c79","article-title":"'State-of-the-heart' of cardiac laminopathies","volume":"28","author":"Cattin","year":"2013","journal-title":"Curr Opin Cardiol"},{"issue":"22","key":"10.1016\/j.hjc.2018.05.008_bib35","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1016\/j.jacc.2016.09.927","article-title":"Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies","volume":"68","author":"Ortiz-genga","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.hjc.2018.05.008_bib36","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.jacc.2006.07.016","article-title":"Phospholamban R14 deletion results in late-onset, mild, hereditary dilated cardiomyopathy","volume":"48","author":"Dewitt","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.hjc.2018.05.008_bib37","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1073\/pnas.0510519103","article-title":"A\u00a0mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy","volume":"103","author":"Haghighi","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"10.1016\/j.hjc.2018.05.008_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2011.07.028","article-title":"Mutations in the human phospholamban gene in patients with heart failure","volume":"162","author":"Medeiros","year":"2011","journal-title":"Am Heart J"},{"issue":"5611","key":"10.1016\/j.hjc.2018.05.008_bib39","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1126\/science.1081578","article-title":"Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban","volume":"299","author":"Schmitt","year":"2003","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.hjc.2018.05.008_bib40","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/S0735-1097(00)00650-1","article-title":"Prevalence and characteristics of dystrophin defects in adult male patients with dilated cardiomyopathy","volume":"35","author":"Arbustini","year":"2000","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.hjc.2018.05.008_bib41","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/6799","article-title":"Mutations in the gene encoding lamin A\/C cause autosomal dominant Emery-Dreifuss muscular dystrophy","volume":"21","author":"Bonne","year":"1999","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.hjc.2018.05.008_bib42","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/jnnp.29.4.338","article-title":"Unusual type of benign x-linked muscular dystrophy","volume":"29","author":"Emery","year":"1966","journal-title":"J\u00a0Neurol Neurosurg Psychiatr"},{"issue":"4","key":"10.1016\/j.hjc.2018.05.008_bib43","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1086\/302869","article-title":"Different mutations in the LMNA gene cause autosomal dominant and autosomal recessive Emery-Dreifuss muscular dystrophy","volume":"66","author":"Raffaele di barletta","year":"2000","journal-title":"Am J Hum Genet"},{"issue":"5","key":"10.1016\/j.hjc.2018.05.008_bib44","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1378\/chest.121.5.1638","article-title":"Alcoholic cardiomyopathy: incidence, clinical characteristics, and pathophysiology","volume":"121","author":"Piano","year":"2002","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.hjc.2018.05.008_bib45","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/oxfordjournals.eurheartj.a062314","article-title":"Normalization of variables of left ventricular function in patients with alcoholic cardiomyopathy after cessation of excessive alcohol intake: an echocardiographic study","volume":"8","author":"Pavan","year":"1987","journal-title":"Eur Heart J"},{"issue":"36","key":"10.1016\/j.hjc.2018.05.008_bib46","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/eurheartj\/ehw211","volume":"37","author":"Zamorano","year":"2016","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.hjc.2018.05.008_bib47","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.amjmed.2010.11.031","article-title":"Chemical cardiomyopathies: the negative effects of medications and nonprescribed drugs on the heart","volume":"124","author":"Figueredo","year":"2011","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.hjc.2018.05.008_bib48","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/clc.4960130505","article-title":"Unrecognized left ventricular dysfunction in an apparently healthy cocaine abuse population","volume":"13","author":"Bertolet","year":"1990","journal-title":"Clin Cardiol"},{"issue":"7","key":"10.1016\/j.hjc.2018.05.008_bib49","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1056\/NEJM199402173300702","article-title":"Coronary-artery vasoconstriction induced by cocaine, cigarette smoking, or both","volume":"330","author":"Moliterno","year":"1994","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.hjc.2018.05.008_bib50","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.amjmed.2006.01.024","article-title":"The association of methamphetamine use and cardiomyopathy in young patients","volume":"120","author":"Yeo","year":"2007","journal-title":"Am J Med"},{"issue":"33","key":"10.1016\/j.hjc.2018.05.008_bib51","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1093\/eurheartj\/eht210","article-title":"Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"34","author":"Caforio","year":"2013","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.hjc.2018.05.008_bib52","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.hjc.2017.08.003","article-title":"Recurrent viral myocarditis: The emerging link toward dilated cardiomyopathy","volume":"59","author":"Nikolaou","year":"2018","journal-title":"Hellenic J Cardiol"},{"issue":"9","key":"10.1016\/j.hjc.2018.05.008_bib53","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.mayocp.2016.05.013","article-title":"Myocarditis in Clinical Practice","volume":"91","author":"Sinagra","year":"2016","journal-title":"Mayo Clin Proc"},{"issue":"8","key":"10.1016\/j.hjc.2018.05.008_bib54","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/eurjhf\/hfq120","article-title":"Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy","volume":"12","author":"Sliwa","year":"2010","journal-title":"Eur J Heart Fail"},{"issue":"20","key":"10.1016\/j.hjc.2018.05.008_bib55","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1161\/CIRCULATIONAHA.109.929646","article-title":"Peripartum cardiomyopathy as a part of familial dilated cardiomyopathy","volume":"121","author":"Van spaendonck-zwarts","year":"2010","journal-title":"Circulation"},{"issue":"32","key":"10.1016\/j.hjc.2018.05.008_bib56","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1093\/eurheartj\/ehu050","article-title":"Titin gene mutations are common in families with both peripartum cardiomyopathy and dilated cardiomyopathy","volume":"35","author":"Van spaendonck-zwarts","year":"2014","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.hjc.2018.05.008_bib57","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.autrev.2013.03.013","article-title":"Cardiovascular disease in autoimmune rheumatic diseases","volume":"12","author":"Hollan","year":"2013","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.hjc.2018.05.008_bib58","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jacc.2016.03.605","article-title":"Cardiac Sarcoidosis","volume":"68","author":"Birnie","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"19","key":"10.1016\/j.hjc.2018.05.008_bib59","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1093\/eurheartj\/ehs397","article-title":"Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases","volume":"34","author":"Rapezzi","year":"2013","journal-title":"Eur Heart J"},{"issue":"25","key":"10.1016\/j.hjc.2018.05.008_bib60","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1016\/j.jacc.2016.03.590","article-title":"The Diagnosis and Evaluation of Dilated Cardiomyopathy","volume":"67","author":"Japp","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.hjc.2018.05.008_bib61","first-page":"1342","article-title":"2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure","volume":"33","author":"Ezekowitz","year":"2017","journal-title":"Can J Cardiol"},{"issue":"27","key":"10.1016\/j.hjc.2018.05.008_bib62","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"issue":"21","key":"10.1016\/j.hjc.2018.05.008_bib63","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1093\/eurheartj\/ehx242","article-title":"Rare Diseases in Cardiovascular Medicine II","volume":"38","author":"Akhtar","year":"2017","journal-title":"Eur Heart J"},{"issue":"18","key":"10.1016\/j.hjc.2018.05.008_bib64","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/j.jacc.2013.12.021","article-title":"Sudden cardiac death risk stratification in patients with nonischemic dilated cardiomyopathy","volume":"63","author":"Goldberger","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.hjc.2018.05.008_bib65","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1161\/CIRCIMAGING.113.001144","article-title":"Late gadolinium enhancement on cardiac magnetic resonance predicts adverse cardiovascular outcomes in nonischemic cardiomyopathy: a systematic review and meta-analysis","volume":"7","author":"Kuruvilla","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.hjc.2018.05.008_bib66","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jchf.2016.09.017","article-title":"Late Gadolinium Enhancement and the Risk for Ventricular Arrhythmias or Sudden Death in Dilated Cardiomyopathy: Systematic Review and Meta-Analysis","volume":"5","author":"Di marco","year":"2017","journal-title":"JACC Heart Fail."},{"key":"10.1016\/j.hjc.2018.05.008_bib67","article-title":"2017 AHA\/ACC\/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: executive Summary","author":"Al-khatib","year":"2017","journal-title":"Heart Rhythm"},{"issue":"3","key":"10.1016\/j.hjc.2018.05.008_bib68","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1161\/CIRCEP.113.000216","article-title":"Primary prevention of sudden cardiac death in a nonischemic dilated cardiomyopathy population: reappraisal of the role of programmed ventricular stimulation","volume":"6","author":"Gatzoulis","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hjc.2018.05.008_bib69","article-title":"Life-saving ICD activation in a high-risk early heart failure dilated cardiomyopathy patient. Is it time to reconsider our primary prevention approach?","author":"Gatzoulis","year":"2017","journal-title":"Hellenic J Cardiol"},{"issue":"4","key":"10.1016\/j.hjc.2018.05.008_bib70","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1023\/A:1021109130276","article-title":"Electrophysiology studies in patients with dilated cardiomyopathies","volume":"6","author":"Hsia","year":"2002","journal-title":"Card Electrophysiol Rev"},{"issue":"41","key":"10.1016\/j.hjc.2018.05.008_bib71","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","volume":"36","author":"Priori","year":"2015","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.hjc.2018.05.008_bib72","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jacc.2011.08.078","article-title":"Risk factors for malignant ventricular arrhythmias in lamin a\/c mutation carriers a European cohort study","volume":"59","author":"Van rijsingen","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.hjc.2018.05.008_bib73","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.hjc.2017.11.014","article-title":"Novel biomarkers in heart failure: How they change clinical decision?","volume":"58","author":"Tousoulis","year":"2017","journal-title":"Hellenic J Cardiol"},{"issue":"6","key":"10.1016\/j.hjc.2018.05.008_bib74","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jacc.2017.04.025","volume":"70","author":"Yancy","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.hjc.2018.05.008_bib75","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004389","article-title":"Novel mitochondria-targeting peptide in heart failure treatment: a randomized, placebo-controlled trial of elamipretide","volume":"10","author":"Daubert","year":"2017","journal-title":"Circ Heart Fail"},{"issue":"4","key":"10.1016\/j.hjc.2018.05.008_bib76","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002639","article-title":"Coenzyme Q10 and heart failure: A state-of-the-art review","volume":"9","author":"Sharma","year":"2016","journal-title":"Circ Heart Fail"},{"issue":"9","key":"10.1016\/j.hjc.2018.05.008_bib77","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.jacc.2011.09.074","article-title":"Update on myocarditis","volume":"59","author":"Kindermann","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"16","key":"10.1016\/j.hjc.2018.05.008_bib78","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/j.jacc.2017.08.050","article-title":"Prognostic value of cardiac magnetic resonance tissue characterization in risk stratifying patients with suspected myocarditis","volume":"70","author":"Gr\u00e4ni","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.hjc.2018.05.008_bib79","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/14779072.2017.1262764","article-title":"Established and novel treatment options in acute myocarditis, with or without heart failure","volume":"15","author":"Lazaros","year":"2017","journal-title":"Expert Rev Cardiovasc Ther"}],"container-title":["Hellenic Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1109966617303706?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1109966617303706?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:11:35Z","timestamp":1761099095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1109966617303706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":79,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S1109966617303706"],"URL":"https:\/\/doi.org\/10.1016\/j.hjc.2018.05.008","relation":{},"ISSN":["1109-9666"],"issn-type":[{"value":"1109-9666","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current perspectives on the diagnosis and management of dilated cardiomyopathy Beyond heart failure: a Cardiomyopathy Clinic Doctor's point of view","name":"articletitle","label":"Article Title"},{"value":"Hellenic Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hjc.2018.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Hellenic Society of Cardiology. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}